{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:31:21Z","timestamp":1789511481025,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T00:00:00Z","timestamp":1516665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","award":["TNSCOP0049"],"award-info":[{"award-number":["TNSCOP0049"]}],"id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["5P30GM110703"],"award-info":[{"award-number":["5P30GM110703"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012359","name":"Promotion and Mutual Aid Corporation for Private Schools of Japan","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012359","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17K15628"],"award-info":[{"award-number":["JP17K15628"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H07356"],"award-info":[{"award-number":["JP16H07356"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kindai University Research Enhancement Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00705-018-3729-6","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T11:52:28Z","timestamp":1516708348000},"page":"1279-1284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunoregulation of Theiler\u2019s virus-induced demyelinating disease by glatiramer acetate without suppression of antiviral immune responses"],"prefix":"10.1007","volume":"163","author":[{"given":"Seiichi","family":"Omura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6477-3457","authenticated-orcid":false,"given":"Fumitaka","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tierra","family":"Range","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesya","family":"Ekshyyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Minagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Steven","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1798-714X","authenticated-orcid":false,"given":"Ikuo","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"key":"3729_CR1","first-page":"227","volume-title":"Viral infections of the nervous system","author":"RT Johnson","year":"1998","unstructured":"Johnson RT (1998) Chronic inflammatory and demyelinating diseases. In: Johnson RT (ed) Viral infections of the nervous system, 2nd edn. Lippincott-Raven, Philadelphia, pp 227\u2013263"},{"key":"3729_CR2","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.4049\/jimmunol.165.4.2278","volume":"165","author":"GF Wu","year":"2000","unstructured":"Wu GF, Dandekar AA, Pewe L, Perlman S (2000) CD4 and CD8 T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 165:2278\u20132286","journal-title":"J Immunol"},{"key":"3729_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1006\/viro.1996.8382","volume":"228","author":"I Tsunoda","year":"1997","unstructured":"Tsunoda I, Kurtz CIB, Fujinami RS (1997) Apoptosis in acute and chronic central nervous system disease induced by Theiler\u2019s murine encephalomyelitis virus. Virology 228:388\u2013393","journal-title":"Virology"},{"key":"3729_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cellimm.2014.10.004","volume":"292","author":"F Sato","year":"2014","unstructured":"Sato F, Omura S, Kawai E, Martinez NE, Acharya MM, Reddy PC, Chaitanya GV, Alexander JS, Tsunoda I (2014) Distinct kinetics of viral replication, T cell infiltration, and fibrosis in three phases of myocarditis following Theiler\u2019s virus infection. Cell Immunol 292:85\u201393","journal-title":"Cell Immunol"},{"key":"3729_CR5","doi-asserted-by":"publisher","first-page":"13049","DOI":"10.1128\/JVI.76.24.13049-13054.2002","volume":"76","author":"K Asakura","year":"2002","unstructured":"Asakura K, Murayama H, Himeda T, Ohara Y (2002) Epitope-tagged L* protein of Theiler\u2019s murine encephalomyelitis virus is expressed in the central nervous system in the acute phase of infection. J Virol 76:13049\u201313054","journal-title":"J Virol"},{"key":"3729_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00281-002-0105-z","volume":"24","author":"I Tsunoda","year":"2002","unstructured":"Tsunoda I, Fujinami RS (2002) Inside-out versus outside-in models for virus induced demyelination: axonal damage triggering demyelination. Springer Semin Immunopathol 24:105\u2013125","journal-title":"Springer Semin Immunopathol"},{"key":"3729_CR7","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1128\/JVI.72.9.7320-7329.1998","volume":"72","author":"PD Murray","year":"1998","unstructured":"Murray PD, Pavelko KD, Leibowitz J, Lin X, Rodriguez M (1998) CD4+ and CD8+ T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol 72:7320\u20137329","journal-title":"J Virol"},{"key":"3729_CR8","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1128\/JVI.69.4.2525-2533.1995","volume":"69","author":"HL Lipton","year":"1995","unstructured":"Lipton HL, Twaddle G, Jelachich ML (1995) The predominant virus antigen burden is present in macrophages in Theiler\u2019s murine encephalomyelitis virus-induced demyelinating disease. J Virol 69:2525\u20132533","journal-title":"J Virol"},{"key":"3729_CR9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nrneurol.2015.14","volume":"11","author":"RM Ransohoff","year":"2015","unstructured":"Ransohoff RM, Hafler DA, Lucchinetti CF (2015) Multiple sclerosis\u2014a quiet revolution. Nat Rev Neurol 11:134\u2013142","journal-title":"Nat Rev Neurol"},{"key":"3729_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/ana.24286","volume":"76","author":"T Plavina","year":"2014","unstructured":"Plavina T, Subramanyam M, Bloomgren G, Richman S, Pace A, Lee S, Schlain B, Campagnolo D, Belachew S, Ticho B (2014) Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 76:802\u2013812","journal-title":"Ann Neurol"},{"key":"3729_CR11","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1096\/fj.01-1023fje","volume":"16","author":"DR Ure","year":"2002","unstructured":"Ure DR, Rodriguez M (2002) Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease. FASEB J 16:1260\u20131262","journal-title":"FASEB J"},{"key":"3729_CR12","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.ajpath.2013.07.006","volume":"183","author":"F Sato","year":"2013","unstructured":"Sato F, Martinez NE, Shahid M, Rose JW, Carlson NG, Tsunoda I (2013) Resveratrol exacerbates both autoimmune and viral models of multiple sclerosis. Am J Pathol 183:1390\u20131396","journal-title":"Am J Pathol"},{"key":"3729_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.expneurol.2012.11.004","volume":"240","author":"R Aharoni","year":"2013","unstructured":"Aharoni R, Sasson E, Blumenfeld-Katzir T, Eilam R, Sela M, Assaf Y, Arnon R (2013) Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate. Exp Neurol 240:130\u2013144","journal-title":"Exp Neurol"},{"key":"3729_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaut.2014.05.005","volume":"54","author":"R Aharoni","year":"2014","unstructured":"Aharoni R (2014) Immunomodulation neuroprotection and remyelination\u2014the fundamental therapeutic effects of glatiramer acetate: a critical review. J Autoimmun 54:81\u201392","journal-title":"J Autoimmun"},{"key":"3729_CR15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jneuroim.2010.04.022","volume":"225","author":"R Aharoni","year":"2010","unstructured":"Aharoni R, Eilam R, Stock A, Vainshtein A, Shezen E, Gal H, Friedman N, Arnon R (2010) Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE. J Neuroimmunol 225:100\u2013111","journal-title":"J Neuroimmunol"},{"key":"3729_CR16","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/bpa.12119","volume":"24","author":"NE Martinez","year":"2014","unstructured":"Martinez NE, Karlsson F, Sato F, Kawai E, Omura S, Minagar A, Grisham MB, Tsunoda I (2014) Protective and detrimental roles for regulatory T cells in a viral model for multiple sclerosis. Brain Pathol 24:436\u2013451","journal-title":"Brain Pathol"},{"key":"3729_CR17","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.2353\/ajpath.2007.070147","volume":"171","author":"I Tsunoda","year":"2007","unstructured":"Tsunoda I, Tanaka T, Saijoh Y, Fujinami RS (2007) Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol 171:1563\u20131575","journal-title":"Am J Pathol"},{"key":"3729_CR18","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0165-5728(01)00250-8","volume":"115","author":"T Brenner","year":"2001","unstructured":"Brenner T, Arnon R, Sela M, Abramsky O, Meiner Z, Riven-Kreitman R, Tarcik N, Teitelbaum D (2001) Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone\u00ae. J Neuroimmunol 115:152\u2013160","journal-title":"J Neuroimmunol"},{"key":"3729_CR19","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00702-009-0272-3","volume":"116","author":"R Arnon","year":"2009","unstructured":"Arnon R, Aharoni R (2009) Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate. J Neural Transm 116:1443\u20131449","journal-title":"J Neural Transm"},{"key":"3729_CR20","doi-asserted-by":"publisher","first-page":"e1000406","DOI":"10.1371\/journal.ppat.1000406","volume":"5","author":"G Zelinskyy","year":"2009","unstructured":"Zelinskyy G, Dietze K, Sparwasser T, Dittmer U (2009) Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus. PLoS Pathog 5:e1000406","journal-title":"PLoS Pathog"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-018-3729-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-3729-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-3729-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T08:25:04Z","timestamp":1589444704000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-018-3729-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["3729"],"URL":"https:\/\/doi.org\/10.1007\/s00705-018-3729-6","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]},"assertion":[{"value":"31 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The decision to publish this article was solely the responsibility of the authors. All statements, opinions, and content presented in this article are those of the authors and do not represent the opinions of Teva. Teva provided a medical accuracy review of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All experimental procedures involving the use of animals were conducted according to the criteria outlined by the NIH and were approved by the IACUC of Louisiana State University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}